new HIV med called Kaletra

October 2000

Abbott is now marketing a new HIV med called Kaletra.It contains TWO protease inhibitors...lopinavir plus a low dose of ritonavir (Norvir).

Lopinavir is the active antiretroviral in Kaletra.

Ritonavir is only a "booster." It inhibits lopinavir metabolism...resulting in higher and more sustained drug levels.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote